Joakim Rehne

Clarity, Quality and Efficiency

Unveiled in April 2026, Brenntag's biopharma brand, Byphar, is aimed at companies in the biopharmaceutical industry. Joakim Rehné, President of Brenntag Pharma EMEA, explains the strategy behind the new brand.

Top-Feature

Zeta GmbH

Modular Automation Moves from Vision to GMP Reality

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

INOSIM GmbH

Predictive Simulation in Pharma Production

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Article

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Brenntag SE